[1-(4-methoxybenzenesulfonyl)-3-oxo-piperazin-2-yl]acetic acid | 828926-01-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [1-(4-methoxybenzenesulfonyl)-3-oxo-piperazin-2-yl]acetic acid
• 英文别名: 2-[1-(4-Methoxyphenyl)sulfonyl-3-oxopiperazin-2-yl]acetic acid
• CAS: 828926-01-8
• 化学式: C₁₃H₁₆N₂O₆S
• 分子量: 328.346
• InChiKey: QSTQISHFAWVGDR-UHFFFAOYSA-N

物化性质

• 密度：
  1.406±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  121
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  [1-(4-methoxybenzenesulfonyl)-3-oxo-piperazin-2-yl]acetic acid 、 (R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-amine dihydrochloride 在 溶剂黄146 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 异丙醇 为溶剂， 生成 2-(1-(4-methoxyphenylsulfonyl)-3-oxopiperazin-2-yl)-N-((R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide
  参考文献：
  名称：

  3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation

  摘要：

  The discovery of novel and highly potent oxopiperazine based B1 receptor antagonists is described. Compared to the previously described arylsulfonylated (R)-3-amino-3-phenylpropionic acid series, the current compounds showed improved in vitro potency and metabolic stability. Compound 17, 2-((2R)-1-((4-methylphenyl)sulfonyl)-3-oxo-2-piperazinyl)-N-((1R)-6-(1-piperidinylmethyl)-1,2,3,4-tetrahydro-1-naphthalenyl) acetamide, showed EC(50) of 10.3 nM in a rabbit biochemical challenge model. The practical syntheses of chiral arylsulfonylated oxopiperazine acetic acids are also described. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.03.115
• 作为产物：
  描述：

  2-(3-氧代-2-哌嗪基)乙酸乙酯 在 吡啶 、 水 、 lithium hydroxide 作用下， 以 1,4-二氧六环 、 甲醇 为溶剂， 生成 [1-(4-methoxybenzenesulfonyl)-3-oxo-piperazin-2-yl]acetic acid
  参考文献：
  名称：

  3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation

  摘要：

  The discovery of novel and highly potent oxopiperazine based B1 receptor antagonists is described. Compared to the previously described arylsulfonylated (R)-3-amino-3-phenylpropionic acid series, the current compounds showed improved in vitro potency and metabolic stability. Compound 17, 2-((2R)-1-((4-methylphenyl)sulfonyl)-3-oxo-2-piperazinyl)-N-((1R)-6-(1-piperidinylmethyl)-1,2,3,4-tetrahydro-1-naphthalenyl) acetamide, showed EC(50) of 10.3 nM in a rabbit biochemical challenge model. The practical syntheses of chiral arylsulfonylated oxopiperazine acetic acids are also described. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.03.115

文献信息

• Piperazine derivatives and methods of use
  申请人：Chen J. Jian

  公开号：US20050014749A1

  公开（公告）日：2005-01-20

  Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对于治疗疼痛和炎症介导的疾病等方面有效。该发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的衍生物，以及用于预防和治疗涉及疼痛、炎症等疾病或其他疾病或病况的药物组合物和方法。该发明还涉及制备这类化合物的方法，以及在这类方法中有用的中间体。
• Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders
  申请人：Amgen Inc.

  公开号：EP1878728A2

  公开（公告）日：2008-01-16

  Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions thereof. The compounds claimed can be used in methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like.

  所选化合物可有效治疗疼痛和疾病，如炎症介导的疾病。本发明包括新型化合物及其药学上可接受的衍生物、药物组合物。所要求的化合物可用于预防和治疗涉及疼痛、炎症等疾病和其他弊病或病症的方法。
• PIPERAZINE DERIVATIVES AND METHODS OF USE
  申请人：AMGEN INC.

  公开号：EP1656355A2

  公开（公告）日：2006-05-17
• US7393852B2
  申请人：——

  公开号：US7393852B2

  公开（公告）日：2008-07-01
• [EN] PIPERAZINE DERIVATIVES AND METHODS OF USE<br/>[FR] DERIVES DE PIPERAZINE ET PROCEDES POUR LES UTILISER
  申请人：AMGEN INC

  公开号：WO2005061467A2

  公开（公告）日：2005-07-07

  Compounds (I) are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.